Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

The Federal Trade Commission in October brought its  long-anticipated  lawsuit against the nation’s three biggest ...

In the world of health, Novo Nordisk stops insulin pen production, Trump's potential health appointments draw attention, and ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Managing diabetes involves a combination of lifestyle and dietary changes, combined with insulin for type 1 diabetics, and ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...